Michel Detheux
Chief Executive Officer
Business Management
iTeos Therapeutics
Belgium
Biography
Michel is a co-founder of iTeos and has served as Chief Executive Officer (on behalf of MG6A Bioconsulting SPRL) since the Company’s incorporation in 2011. Prior to iTeos, Michel gained 15 years of biotech expertise in target discovery, business development, managerial and commercial responsibilities at Euroscreen before joining Ludwig Cancer Research to found iTeos. Michel holds a Bioengineering degree and a Ph.D. in Biochemistry from UCL and a business certificate from Solvay Business School. He has authored 50 peer-reviewed publications and is an inventor of 27 patents.
Research Interest
business development
